<i>EIF4G1</i> and <i>RAN</i> as Possible Drivers for Malignant Pleural Mesothelioma

For malignant pleural mesothelioma (MPM) novel therapeutic strategies are urgently needed. In a previous study, we identified 51 putative cancer genes over-expressed in MPM tissues and cell lines. Here, we deepened the study on nine of them (<i>ASS1</i>, <i>EIF4G1</i>, <i&...

Full description

Bibliographic Details
Main Authors: Irene Dell’Anno, Marcella Barbarino, Elisa Barone, Antonio Giordano, Luca Luzzi, Maria Bottaro, Loredana Migliore, Silvia Agostini, Alessandra Melani, Ombretta Melaiu, Calogerina Catalano, Monica Cipollini, Roberto Silvestri, Alda Corrado, Federica Gemignani, Stefano Landi
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/14/4856
_version_ 1797562911856525312
author Irene Dell’Anno
Marcella Barbarino
Elisa Barone
Antonio Giordano
Luca Luzzi
Maria Bottaro
Loredana Migliore
Silvia Agostini
Alessandra Melani
Ombretta Melaiu
Calogerina Catalano
Monica Cipollini
Roberto Silvestri
Alda Corrado
Federica Gemignani
Stefano Landi
author_facet Irene Dell’Anno
Marcella Barbarino
Elisa Barone
Antonio Giordano
Luca Luzzi
Maria Bottaro
Loredana Migliore
Silvia Agostini
Alessandra Melani
Ombretta Melaiu
Calogerina Catalano
Monica Cipollini
Roberto Silvestri
Alda Corrado
Federica Gemignani
Stefano Landi
author_sort Irene Dell’Anno
collection DOAJ
description For malignant pleural mesothelioma (MPM) novel therapeutic strategies are urgently needed. In a previous study, we identified 51 putative cancer genes over-expressed in MPM tissues and cell lines. Here, we deepened the study on nine of them (<i>ASS1</i>, <i>EIF4G1</i>, <i>GALNT7</i>, <i>GLUT1</i>, <i>IGF2BP3</i> (<i>IMP3</i>), <i>ITGA4</i>, <i>RAN</i>, <i>SOD1</i>, and <i>THBS2</i>) to ascertain whether they are truly mesothelial cancer driver genes (CDGs) or genes overexpressed in an adaptive response to the tumoral progression (“passenger genes”). Through a fast siRNA-based screening, we evaluated the consequences of gene depletion on migration, proliferation, colony formation capabilities, and caspase activities of four MPM (Mero-14, Mero-25, IST-Mes2, and NCI-H28) and one SV40-immortalized mesothelial cell line (MeT-5A) as a non-malignant model. The depletion of <i>EIF4G1</i> and <i>RAN</i> significantly reduced cell proliferation and colony formation and increased caspase activity. In particular, the findings for RAN resemble those observed for other types of cancer. Thus, we evaluated the in vitro effects of importazole (IPZ), a small molecule inhibitor of the interaction between RAN and importin-β. We showed that IPZ could have effects similar to those observed following <i>RAN</i> gene silencing. We also found that primary cell lines from one out of three MPM patients were sensitive to IPZ. As <i>EIF4G1</i> and <i>RAN</i> deserve further investigation with additional in vitro and in vivo studies, they emerged as promising CDGs, suggesting that their upregulation could play a role in mesothelial tumorigenesis and aggressiveness. Furthermore, present data propose the molecular pathways dependent on RAN as a putative pharmacological target for MPM patients in the view of a future personalized medicine.
first_indexed 2024-03-10T18:35:20Z
format Article
id doaj.art-2d29070c916e4f4084c7c9a969844b5d
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T18:35:20Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-2d29070c916e4f4084c7c9a969844b5d2023-11-20T06:16:54ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-07-012114485610.3390/ijms21144856<i>EIF4G1</i> and <i>RAN</i> as Possible Drivers for Malignant Pleural MesotheliomaIrene Dell’Anno0Marcella Barbarino1Elisa Barone2Antonio Giordano3Luca Luzzi4Maria Bottaro5Loredana Migliore6Silvia Agostini7Alessandra Melani8Ombretta Melaiu9Calogerina Catalano10Monica Cipollini11Roberto Silvestri12Alda Corrado13Federica Gemignani14Stefano Landi15Department of Biology, Genetic Unit, University of Pisa, 56126 Pisa, ItalyDepartment of Medical Biotechnologies, University of Siena, 53100 Siena, ItalyDepartment of Biology, Genetic Unit, University of Pisa, 56126 Pisa, ItalyDepartment of Medical Biotechnologies, University of Siena, 53100 Siena, ItalyDepartment of Medicine, Surgery and Neurosciences, Siena University Hospital, 53100 Siena, ItalyDepartment of Medical Biotechnologies, University of Siena, 53100 Siena, ItalyDepartment of Biology, Genetic Unit, University of Pisa, 56126 Pisa, ItalyDepartment of Biology, Genetic Unit, University of Pisa, 56126 Pisa, ItalyDepartment of Biology, Genetic Unit, University of Pisa, 56126 Pisa, ItalyDepartment of Biology, Genetic Unit, University of Pisa, 56126 Pisa, ItalyDepartment of Biology, Genetic Unit, University of Pisa, 56126 Pisa, ItalyDepartment of Biology, Genetic Unit, University of Pisa, 56126 Pisa, ItalyDepartment of Biology, Genetic Unit, University of Pisa, 56126 Pisa, ItalyDepartment of Biology, Genetic Unit, University of Pisa, 56126 Pisa, ItalyDepartment of Biology, Genetic Unit, University of Pisa, 56126 Pisa, ItalyDepartment of Biology, Genetic Unit, University of Pisa, 56126 Pisa, ItalyFor malignant pleural mesothelioma (MPM) novel therapeutic strategies are urgently needed. In a previous study, we identified 51 putative cancer genes over-expressed in MPM tissues and cell lines. Here, we deepened the study on nine of them (<i>ASS1</i>, <i>EIF4G1</i>, <i>GALNT7</i>, <i>GLUT1</i>, <i>IGF2BP3</i> (<i>IMP3</i>), <i>ITGA4</i>, <i>RAN</i>, <i>SOD1</i>, and <i>THBS2</i>) to ascertain whether they are truly mesothelial cancer driver genes (CDGs) or genes overexpressed in an adaptive response to the tumoral progression (“passenger genes”). Through a fast siRNA-based screening, we evaluated the consequences of gene depletion on migration, proliferation, colony formation capabilities, and caspase activities of four MPM (Mero-14, Mero-25, IST-Mes2, and NCI-H28) and one SV40-immortalized mesothelial cell line (MeT-5A) as a non-malignant model. The depletion of <i>EIF4G1</i> and <i>RAN</i> significantly reduced cell proliferation and colony formation and increased caspase activity. In particular, the findings for RAN resemble those observed for other types of cancer. Thus, we evaluated the in vitro effects of importazole (IPZ), a small molecule inhibitor of the interaction between RAN and importin-β. We showed that IPZ could have effects similar to those observed following <i>RAN</i> gene silencing. We also found that primary cell lines from one out of three MPM patients were sensitive to IPZ. As <i>EIF4G1</i> and <i>RAN</i> deserve further investigation with additional in vitro and in vivo studies, they emerged as promising CDGs, suggesting that their upregulation could play a role in mesothelial tumorigenesis and aggressiveness. Furthermore, present data propose the molecular pathways dependent on RAN as a putative pharmacological target for MPM patients in the view of a future personalized medicine.https://www.mdpi.com/1422-0067/21/14/4856cancer driving geneEIF4G1MPMRANsiRNAimportazole
spellingShingle Irene Dell’Anno
Marcella Barbarino
Elisa Barone
Antonio Giordano
Luca Luzzi
Maria Bottaro
Loredana Migliore
Silvia Agostini
Alessandra Melani
Ombretta Melaiu
Calogerina Catalano
Monica Cipollini
Roberto Silvestri
Alda Corrado
Federica Gemignani
Stefano Landi
<i>EIF4G1</i> and <i>RAN</i> as Possible Drivers for Malignant Pleural Mesothelioma
International Journal of Molecular Sciences
cancer driving gene
EIF4G1
MPM
RAN
siRNA
importazole
title <i>EIF4G1</i> and <i>RAN</i> as Possible Drivers for Malignant Pleural Mesothelioma
title_full <i>EIF4G1</i> and <i>RAN</i> as Possible Drivers for Malignant Pleural Mesothelioma
title_fullStr <i>EIF4G1</i> and <i>RAN</i> as Possible Drivers for Malignant Pleural Mesothelioma
title_full_unstemmed <i>EIF4G1</i> and <i>RAN</i> as Possible Drivers for Malignant Pleural Mesothelioma
title_short <i>EIF4G1</i> and <i>RAN</i> as Possible Drivers for Malignant Pleural Mesothelioma
title_sort i eif4g1 i and i ran i as possible drivers for malignant pleural mesothelioma
topic cancer driving gene
EIF4G1
MPM
RAN
siRNA
importazole
url https://www.mdpi.com/1422-0067/21/14/4856
work_keys_str_mv AT irenedellanno ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT marcellabarbarino ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT elisabarone ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT antoniogiordano ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT lucaluzzi ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT mariabottaro ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT loredanamigliore ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT silviaagostini ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT alessandramelani ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT ombrettamelaiu ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT calogerinacatalano ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT monicacipollini ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT robertosilvestri ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT aldacorrado ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT federicagemignani ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma
AT stefanolandi ieif4g1iandiraniaspossibledriversformalignantpleuralmesothelioma